Supriya Pharmaceuticals Limited
About Supriya Pharmaceuticals Limited
Data last updated: 08 January 2026
Supriya Pharmaceuticals Limited is a public limited company based in New Delhi, Delhi, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 24 July 1985, the company has been in operation for over 41 years.
Registered with ROC Delhi under CIN U24232RJ1985PLC003363.
Capital: an authorised share capital of ₹10 Cr and a paid-up capital of ₹9.64 Cr. It is led by directors including Manish Gupta and Ramesh Dugar.
Last AGM: 04 June 2025. Financial statements filed for year ended 31 March 2025. Office: 810 Arunachal Building, 19 Barkhamba Road Connaught Place, New Delhi, Delhi, India – 110001.
As per MCA filings, the company has open charges of ₹3 Cr and satisfied charges of ₹7.94 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
-
EmailLocked
-
TelephoneLocked
-
WebsiteLocked
-
Social MediaLocked
-
Registered Address810 Arunachal Building, 19 Barkhamba Road Connaught Place, New Delhi, Delhi, India – 110001
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Supriya Pharmaceuticals Limited
Supriya Pharmaceuticals Limited has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U01100DL1985PLC445217, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U01100DL1985PLC445217 | Current |
| U24232RJ1985PLC003363 | Previous |
| L24232RJ1985PLC003363 | Previous |
| U01100RJ1985PLC003363 | Previous |
Business Activity of Supriya Pharmaceuticals Limited
Supriya Pharmaceuticals Limited operates primarily in the manufacturing sector. The company has 1 registered business activity segment, reflecting its diverse operational portfolio.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Locked | Manufacturing | Locked | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Detailed business activity records for Supriya Pharmaceuticals Limited
Activity codes and turnover contribution percentages require an active report plan.
- Activity group codes
- Detailed activity codes
- Turnover contribution
Verified entity values are shown only after access is granted.
Board of Directors of Supriya Pharmaceuticals Limited
Supriya Pharmaceuticals Limited is currently managed by 3 directors, with 14 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manish Gupta | Nominee Director | 06 Feb 2024 | 2 Years 5 Months | Current |
|
Ramesh Dugar
Also directs:
Dakesh Builders Pvt Ltd, Tarini Overseas Private Limited, R Net Intelligence Systems Private Limited and 3 more
|
Nominee Director | 08 Feb 2012 | 14 Years 5 Months | Current |
|
Yogesh Kumar
Also directs:
Trancelogics Private Limited
|
Nominee Director | 16 May 2017 | 9 Years 2 Months | Current |
Financials of Supriya Pharmaceuticals Limited FY 2025 filings available
Ten-year financial statements for Supriya Pharmaceuticals Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings of Supriya Pharmaceuticals Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Aug 2005 | United Bank of India | ₹3 Cr | Satisfied |
| 21 Jan 1998 | Canara Bank | ₹3 Lakh | Satisfied |
| 20 Aug 1992 | Canara Bank | ₹3 Cr | Satisfied |
| 31 Jan 1992 | Canara Bank | ₹30 Lakh | Satisfied |
| 16 Aug 1991 | Canara Bank | ₹55 Lakh | Satisfied |
Total charge records: 9 View all charges
Employees and EPFO Compliance at Supriya Pharmaceuticals Limited
View historical data on people associated with Supriya Pharmaceuticals Limited, including employment history and EPFO contributions.
Employee and EPFO history for Supriya Pharmaceuticals Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Supriya Pharmaceuticals Limited
GST registrations and filing compliance for Supriya Pharmaceuticals Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Supriya Pharmaceuticals Limited
Credit ratings, litigation, and regulatory alerts for Supriya Pharmaceuticals Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Supriya Pharmaceuticals Limited
MSME payment history for Supriya Pharmaceuticals Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Supriya Pharmaceuticals Limited
Corporate group structure for Supriya Pharmaceuticals Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Supriya Pharmaceuticals Limited
MCA filings and documents for Supriya Pharmaceuticals Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Supriya Pharmaceuticals Limited
Frequently Asked Questions about Supriya Pharmaceuticals Limited
Supriya Pharmaceuticals Limited is an active public limited company in the pharma sector based in New Delhi, Delhi, India. It was incorporated on 24 July 1985 (41+ years old) and is registered under CIN U01100DL1985PLC445217.
The current directors of Supriya Pharmaceuticals Limited are:
- Manish Gupta - Nominee Director
- Ramesh Dugar - Nominee Director
- Yogesh Kumar - Nominee Director
The primary industry of Supriya Pharmaceuticals Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Supriya Pharmaceuticals Limited can be reached at the registered office: 810 Arunachal Building, 19 Barkhamba Road Connaught Place, New Delhi, Delhi, India – 110001.
The authorised capital is ₹10 Cr, and the paid-up capital is ₹9.64 Cr.
The company has its registered office at 810 Arunachal Building, 19 Barkhamba Road Connaught Place, New Delhi, Delhi, India – 110001.